TEVANYSEPharmaceutical PreparationsFiscal year ends December 31
TEVA PHARMACEUTICAL INDUSTRIES LTD
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 29, 2026
$41.31−0.19 (-0.46%)
Close on Oct 19, 2026
- Market cap
- $48.13B
- P/E (TTM)
- 68.9
- Dividend yield
- –
Ownership
Who owns Teva Pharmaceutical Industries's shares
Held by institutions
–
Shares held, 13F filers
Institutional holders
–
Net institutional buying
–
Insider trades, 12 months
0 buys · 58 sales
Net sold $113.29M
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Harel Insurance Investments & Financial Services Ltd | 72,325,555 | 6.30% | 13G (passive) amendment | Dec 31, 2025 |
| Migdal Insurance & Financial Holdings Ltd | 61,689,363 | 5.37% | 13G (passive) | Dec 31, 2025 |
| Abigail P. Johnson | 58,135,616 | 5.10% | 13G (passive) amendment | Jun 30, 2025 |
| Menora Mivtachim Holdings Ltd | 57,395,173 | 5.00% | 13G (passive) | Jul 16, 2025 |
| Phoenix Financial Ltd. | 57,383,158 | 5.00% | 13G (passive) | Jul 14, 2025 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Brian Savage | Interim Chief Legal Officer | 15,842 | 0.00% | Sep 22, 2026 |
| Amir Weiss | Chief Accounting Officer | 13,071 | 0.00% | Aug 25, 2026 |
| Evan Lippman | EVP, Business Development | 25,591 | 0.00% | Aug 19, 2026 |
| Placid Jover | "See ""Remarks""" | 19,601 | 0.00% | Aug 5, 2026 |
| Eric A. Hughes | "See ""Remarks""" | 134,877 | 0.01% | Aug 5, 2026 |
| Matthew Shields | EVP, Global Operations | 0 | – | Jun 22, 2026 |
| Eliyahu Sharon Kalif | EVP, Chief Financial Officer | 65,621 | 0.01% | Jun 16, 2026 |
| Richard D. Francis | President and CEO | 1,183,682 | 0.10% | Jun 8, 2026 |
| Richard Daniell | EVP, Europe Commercial | 55,755 | 0.00% | May 7, 2026 |
| Christine Fox | EVP, U.S. Commercial | 63,647 | 0.01% | May 4, 2026 |
| Mark Sabag | "See ""Remarks""" | 80,760 | 0.01% | May 4, 2026 |
| David R. McAvoy | EVP, Chief Legal Officer | 13,027 | 0.00% | Sep 9, 2025 |
| Roberto Mignone | Director | 119,807 | 0.01% | Sep 22, 2026 |
| Ronit Satchi-Fainaro | Director | 111,986 | 0.01% | Aug 25, 2026 |
| Tal Zvi Zaks | Director | 73,247 | 0.01% | Aug 10, 2026 |
| Rosemary A. Crane | Director | 127,739 | 0.01% | Jun 8, 2026 |
| Sol J. Barer | Director | 448,011 | 0.04% | Jun 8, 2026 |
| Gerald M. Lieberman | Director | 130,149 | 0.01% | Jun 8, 2026 |
| Perry Nisen | Director | 119,807 | 0.01% | Jun 8, 2026 |
| Chen Lichtenstein | Director | 19,296 | 0.00% | Jun 8, 2026 |
| Amir Elstein | Director | 2,118,455 | 0.18% | Jun 8, 2026 |
| Varda Shalev | Director | 22,504 | 0.00% | Jun 9, 2025 |
| Janet S. Vergis | Director | 73,697 | 0.01% | Jun 9, 2025 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Brian Savage Interim Chief Legal Officer | Sep 18, 2026 | Option exercise | +4,503 | $34.70 | $156.25K | 15,842 |
| Brian Savage Interim Chief Legal Officer | Sep 18, 2026 | Sale | −4,503 | $38.69 | $174.22K | 11,339 |
| Brian Savage Interim Chief Legal Officer | Sep 18, 2026 | Sale | −2,525 | $39.15 | $98.85K | 8,814 |
| Brian Savage Interim Chief Legal Officer | Sep 18, 2026 | Sale | −314 | $38.70 | $12.15K | 8,500 |
| Roberto Mignone Director | Sep 18, 2026 | Sale | −367,600 | $39.06 | $14.36M | 0 |
| Amir Weiss Chief Accounting Officer | Aug 21, 2026 | Sale | −6,945 | $37.61 | $261.20K | 13,071 |
| Amir Weiss Chief Accounting Officer | Aug 21, 2026 | Sale | −2,500 | $37.63 | $94.08K | 13,071 |
| Amir Weiss Chief Accounting Officer | Aug 21, 2026 | Option exercise | +2,500 | $19.61 | $49.03K | 15,571 |
| Ronit Satchi-Fainaro Director | Aug 21, 2026 | Sale | −415 | $37.25 | $15.46K | 111,986 |
| Evan Lippman EVP, Business Development | Aug 17, 2026 | Sale(10b5-1 plan) | −18,600 | $36.57 | $680.20K | 25,591 |
| Tal Zvi Zaks Director | Aug 5, 2026 | Sale | −17 | $34.87 | $593 | 73,247 |
| Eric A. Hughes "See ""Remarks""" | Aug 3, 2026 | Sale(10b5-1 plan) | −25,578 | $34.88 | $892.16K | 134,877 |
| Eric A. Hughes "See ""Remarks""" | Aug 3, 2026 | Option exercise | +52,744 | – | – | 160,455 |
| Placid Jover "See ""Remarks""" | Aug 3, 2026 | Option exercise | +12,827 | – | – | 19,601 |
| Placid Jover "See ""Remarks""" | Aug 3, 2026 | Sale(10b5-1 plan) | −12,827 | $34.88 | $447.41K | 6,774 |
| Matthew Shields EVP, Global Operations | Jun 18, 2026 | Sale | −9,989 | $32.19 | $321.55K | 0 |
| Eliyahu Sharon Kalif EVP, Chief Financial Officer | Jun 11, 2026 | Sale(10b5-1 plan) | −106,563 | $34.10 | $3.63M | 65,621 |
| Roberto Mignone Director | Jun 5, 2026 | Option exercise | +14,492 | – | – | 119,807 |
| Rosemary A. Crane Director | Jun 5, 2026 | Option exercise | +14,492 | – | – | 127,739 |
| Richard D. Francis President and CEO | Jun 5, 2026 | Option exercise | +13,043 | – | – | 1,183,682 |
| Richard D. Francis President and CEO | Jun 5, 2026 | Sale(10b5-1 plan) | −6,153 | $34.35 | $211.36K | 1,177,529 |
| Ronit Satchi-Fainaro Director | Jun 5, 2026 | Option exercise | +14,492 | – | – | 112,401 |
| Gerald M. Lieberman Director | Jun 5, 2026 | Option exercise | +14,492 | – | – | 130,149 |
| Amir Elstein Director | Jun 5, 2026 | Option exercise | +14,492 | – | – | 2,118,455 |
| Perry Nisen Director | Jun 5, 2026 | Option exercise | +14,492 | – | – | 119,807 |
| Chen Lichtenstein Director | Jun 5, 2026 | Option exercise | +14,492 | – | – | 19,296 |
| Tal Zvi Zaks Director | Jun 5, 2026 | Option exercise | +14,492 | – | – | 73,264 |
| Sol J. Barer Director | Jun 5, 2026 | Option exercise | +21,739 | – | – | 448,011 |
| Matthew Shields EVP, Global Operations | Jun 3, 2026 | Sale(10b5-1 plan) | −16,195 | $32.87 | $532.33K | 9,989 |
| Matthew Shields EVP, Global Operations | Jun 3, 2026 | Option exercise | +16,195 | – | – | 26,184 |
| Eliyahu Sharon Kalif EVP, Chief Financial Officer | May 14, 2026 | Sale(10b5-1 plan) | −153,251 | $35.61 | $5.46M | 172,184 |
| Evan Lippman EVP, Business Development | May 14, 2026 | Sale(10b5-1 plan) | −35,912 | $35.58 | $1.28M | 44,191 |
| Evan Lippman EVP, Business Development | May 14, 2026 | Option exercise | +11,841 | – | – | 11,841 |
| Evan Lippman EVP, Business Development | May 14, 2026 | Sale(10b5-1 plan) | −5,746 | $35.58 | $204.44K | 6,095 |
| Evan Lippman EVP, Business Development | May 14, 2026 | Option exercise | +74,008 | – | – | 80,103 |
| Amir Weiss Chief Accounting Officer | May 6, 2026 | Sale | −10,679 | $36.00 | $384.44K | 20,016 |
| Richard Daniell EVP, Europe Commercial | May 5, 2026 | Sale | −30,000 | $35.40 | $1.06M | 55,755 |
| Mark Sabag "See ""Remarks""" | May 1, 2026 | Sale | −144,180 | $34.99 | $5.04M | 80,760 |
| Christine Fox EVP, U.S. Commercial | Apr 30, 2026 | Sale | −21,258 | $35.31 | $750.62K | 63,647 |
| Mark Sabag "See ""Remarks""" | Mar 17, 2026 | Sale | −62,102 | $30.14 | $1.87M | 224,940 |
| Richard D. Francis President and CEO | Mar 5, 2026 | Sale(10b5-1 plan) | −20,025 | $31.67 | $634.19K | 1,170,639 |
| Richard D. Francis President and CEO | Mar 5, 2026 | Option exercise | +42,452 | – | – | 1,190,664 |
| Matthew Shields EVP, Global Operations | Mar 5, 2026 | Option exercise | +17,295 | – | – | 27,284 |
| Matthew Shields EVP, Global Operations | Mar 5, 2026 | Sale(10b5-1 plan) | −17,295 | $31.67 | $547.73K | 9,989 |
| Richard Daniell EVP, Europe Commercial | Mar 5, 2026 | Option exercise | +17,295 | – | – | 103,050 |
| Richard Daniell EVP, Europe Commercial | Mar 5, 2026 | Sale(10b5-1 plan) | −17,295 | $31.67 | $547.73K | 85,755 |
| Eric A. Hughes "See ""Remarks""" | Mar 5, 2026 | Sale(10b5-1 plan) | −9,533 | $31.67 | $301.91K | 107,711 |
| Eric A. Hughes "See ""Remarks""" | Mar 5, 2026 | Option exercise | +19,654 | – | – | 117,244 |
| Eliyahu Sharon Kalif EVP, Chief Financial Officer | Mar 5, 2026 | Option exercise | +19,916 | – | – | 325,435 |
| Mark Sabag "See ""Remarks""" | Mar 5, 2026 | Option exercise | +15,723 | – | – | 287,042 |
| Placid Jover "See ""Remarks""" | Mar 5, 2026 | Option exercise | +14,150 | – | – | 20,924 |
| Placid Jover "See ""Remarks""" | Mar 5, 2026 | Sale(10b5-1 plan) | −14,150 | $31.67 | $448.13K | 6,774 |
| Brian Savage Interim Chief Legal Officer | Mar 5, 2026 | Sale | −1,127 | $31.67 | $35.69K | 10,914 |
| Brian Savage Interim Chief Legal Officer | Mar 5, 2026 | Option exercise | +3,580 | – | – | 12,041 |
| Amir Weiss Chief Accounting Officer | Mar 5, 2026 | Option exercise | +3,537 | – | – | 30,695 |
| Christine Fox EVP, U.S. Commercial | Mar 5, 2026 | Option exercise | +17,819 | – | – | 92,829 |
| Christine Fox EVP, U.S. Commercial | Mar 5, 2026 | Sale(10b5-1 plan) | −7,924 | $31.67 | $250.95K | 84,905 |
| Christine Fox EVP, U.S. Commercial | Mar 4, 2026 | Sale(10b5-1 plan) | −9,098 | $32.46 | $295.32K | 75,010 |
| Christine Fox EVP, U.S. Commercial | Mar 4, 2026 | Option exercise | +20,461 | – | – | 84,108 |
| Richard D. Francis President and CEO | Mar 4, 2026 | Sale(10b5-1 plan) | −23,393 | $32.46 | $759.34K | 1,148,212 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| Brian Savage Officer, CHIEF LEGAL OFFICER | Sep 21, 2026 | 7,028 | $273.06K | Sep 18, 2026 | SHARES FROM ROLLOVER |
| Bridger Management, LLC (1) Shareholder | Sep 18, 2026 | 367,600 | $14.41M | Sep 18, 2026 | See Remark 2 |
| Evan Lippman Officer, EVP BUSINESS DEVELOPMENT | Aug 17, 2026 | 18,600 | $680.29K | Aug 17, 2026 | Shares from Rollover, ADR |
| Eric A. Hughes Executive VP Global R&D and Chief Med Officer | Aug 3, 2026 | 25,578 | $892.05K | Aug 3, 2026 | Restricted Share Unit Award Vesting |
| Placid Jover Executive VP, Chief HR Officer | Aug 3, 2026 | 12,827 | $447.35K | Aug 3, 2026 | Restricted Share Unit Award Vesting |
| Matthew Shields Officer, EXECUTIVE VP TEVA GLOBAL OPERATIONS | Jun 18, 2026 | 9,989 | $321.55K | Jun 18, 2026 | SHARES FROM ROLLOVER |
| Eliyahu Sharon Kalif Officer, EVP CHIEF FINANCIAL OFFICER | Jun 11, 2026 | 106,563 | $3.63M | Jun 11, 2026 | SHARES FROM ROLLOVER |
| Richard D. Francis Officer, PRESIDENT AND CEO | Jun 5, 2026 | 6,153 | $211.36K | Jun 5, 2026 | RESTRICTED SHARE UNIT AWARD VESTING |
| Matthew Shields Officer, EXECUTIVE VP TEVA GLOBAL OPERATIONS | Jun 3, 2026 | 16,195 | $532.33K | Jun 3, 2026 | RESTRICTED SHARE UNIT AWARD VESTING |
| Evan Lippman Officer, EXECUTIVE VP BUSINESS DEVELOPMENT | May 14, 2026 | 41,658 | $1.48M | May 14, 2026 | RESTRICTED SHARE UNIT AWARD VESTING |
| Eliyahu Sharon Kalif Officer, EVP CHIEF FINANCIAL OFFICER | May 14, 2026 | 153,251 | $5.46M | May 14, 2026 | SHARES FROM ROLLOVER |
| Richard Daniell Officer, EXECUTIVE VP EUROPEAN COMMERCIAL | May 5, 2026 | 30,000 | $1.06M | May 5, 2026 | SHARES FROM ROLLOVER |
| Mark Sabag Officer, EXECUTIVE VP INTERNATIONAL MARKETS COMMERCIAL | May 4, 2026 | 144,180 | $5.05M | May 1, 2026 | SHARES FROM ROLLOVER |
| Fox Christine Officer | Apr 30, 2026 | 21,258 | $750.63K | Apr 30, 2026 | Vesting of a Stock Award |
| Mark Sabag Officer, EXECUTIVE VP INTERNATIONAL MARKETS COMMERCIAL | Mar 17, 2026 | 62,102 | $1.87M | Mar 17, 2026 | SHARES FROM ROLLOVER |